stockrow
Saturday 7 November 2026
Export CYH’s income statement to Excel — free account
Community Health Systems, Inc.
CYH Healthcare Medical Care Facilities
Community Health Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.5 billion, down 1.18% from fiscal 2024.
- Revenue
- −10.7%
- EPS
- −138.0%
- Free cash flow
- +857.1%
- Total debt
- −9.61%
Quarter to September 2026, against a year earlier
2.21
0.07
−3.07%
Follow CYH
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.82 | 0.00 | 0.00 | 12.22 | 7.39 | 1.70 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
8 | 4 | 5 | 5 | 3 | 6 | 5 | 5 | 4 | 5 |
P/S ratio |
0.03 | 0.03 | 0.03 | 0.05 | 0.14 | 0.07 | 0.03 | 0.02 | 0.03 | 0.03 |
Altman Z-Score |
1.05 | 0.72 | 0.84 | 0.78 | 0.95 | 0.80 | 0.70 | 0.72 | 0.44 | 0.81 |
Altman Z″-Score (non-manufacturers) |
0.30 | (0.35) | 0.05 | (0.07) | 0.27 | 0.32 | (0.25) | (0.25) | (0.64) | 0.31 |
P/FCF ratio |
1.93 | 3.16 | 0.00 | 0.00 | 0.00 | 0.49 | 0.00 | 0.00 | 2.32 | 1.58 |
Beneish M-Score |
(2.52) | (2.75) | (2.46) | (2.52) | (2.23) | (3.08) | (2.77) | (2.75) | (3.66) | (3.23) |
P/Operating CF |
1.57 | 1.83 | 4.58 | 62.97 | (3.18) | 11.29 | 1.70 | (1.91) | 3.21 | 1.97 |
Dividend Safety Score |
35 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.85 | 0.93 | 0.95 | 0.99 | 1.08 | 0.97 | 1.02 | 0.97 | 0.90 | 0.85 |
EV/EBITDA |
5.51 | 11.49 | 8.11 | 8.92 | 6.86 | 6.77 | 10.75 | 15.11 | 0.00 | 65.21 |
EV/Operating CF |
19.43 | 24.60 | 56.48 | 40.28 | (101.68) | 5.23 | 35.11 | 50.07 | 17.92 | 13.76 |
EV/FCF |
48.86 | 94.48 | (51.80) | (156.93) | (22.58) | 6.54 | (270.38) | (55.99) | 64.12 | 38.36 |
Quick Ratio |
1.06 | 0.99 | 1.06 | 0.99 | 1.09 | 1.28 | 1.08 | 1.07 | 1.25 | 1.18 |
Current Ratio |
1.46 | 1.41 | 1.50 | 1.41 | 1.47 | 1.60 | 1.50 | 1.48 | 1.73 | 1.62 |
Net Debt/EBITDA |
5.30 | 11.10 | 7.83 | 8.50 | 5.99 | 6.26 | 10.48 | 14.76 | (13.13) | 62.53 |
Debt/Assets |
78.73% | 81.49% | 79.47% | 79.32% | 79.78% | 76.32% | 85.88% | 85.73% | 79.73% | 69.47% |
Debt/Equity |
(8.97) | (6.83) | (10.01) | (9.13) | (9.41) | (7.94) | (6.26) | (9.29) | (20.11) | 8.82 |
Asset Turnover |
0.92 | 0.89 | 0.86 | 0.82 | 0.79 | 0.75 | 0.84 | 0.85 | 0.78 | 0.76 |
Operating CF/Net income |
1.07 | (0.93) | (1.58) | 6.52 | (0.57) | 4.26 | (0.57) | (0.35) | (0.31) | (0.66) |
Capex/Depreciation |
(0.77) | (0.73) | (0.87) | (0.71) | (0.85) | (0.78) | (0.72) | (0.74) | (0.65) | (0.66) |
Interest Coverage |
1.71 | 0.63 | 1.15 | 0.96 | 1.58 | 1.09 | 0.62 | 0.21 | (2.02) | (0.89) |
| (35.91%) | 36.56% | 10.98% | (3.59%) | (16.27%) | (27.78%) | 37.46% | 73.13% | (474.71%) | (59.01%) | |
| 3.73% | (3.62%) | (0.91%) | 0.31% | 1.47% | 3.23% | (4.29%) | (4.73%) | (12.48%) | (7.09%) | |
ROIC |
10.36% | 3.48% | 5.81% | 5.01% | 8.47% | 7.82% | 3.68% | 1.09% | (9.27%) | (3.21%) |
Return on Tangible Assets |
9.21% | (9.00%) | (2.12%) | 0.73% | 3.45% | 7.28% | (10.00%) | (10.80%) | (28.06%) | (17.33%) |
Average Days of Receivables |
60.72 | 66.04 | 65.20 | 60.98 | 60.85 | 59.66 | 62.39 | 60.65 | 56.68 | 62.87 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
43.35% | 42.88% | 43.35% | 43.65% | 42.38% | 45.90% | 45.02% | 45.10% | 48.04% | 46.77% |
Intangible Assets out of Total Assets |
0.25 | 0.27 | 0.27 | 0.28 | 0.28 | 0.26 | 0.28 | 0.29 | 0.27 | 0.30 |
Share Based Compensation of Revenue |
0.09% | 0.13% | 0.18% | 0.16% | 0.20% | 0.11% | 0.08% | 0.09% | 0.16% | 0.25% |
Graham Net Nets |
(26.71) | (31.47) | (30.07) | (22.69) | (7.72) | (15.19) | (43.42) | (43.33) | (28.11) | (24.17) |
Graham Number |
0.00 | 33.37 | 14.28 | 0.00 | 0.00 | 0.00 | 50.12 | 45.15 | 55.32 | 0.00 |
Earnings Yield |
121.79% | (130.43%) | (32.59%) | 8.18% | 13.52% | 58.95% | (204.48%) | (247.52%) | (490.40%) | (266.95%) |
Free Cash Flow Yield |
51.83% | 31.65% | (55.55%) | (13.59%) | (34.97%) | 203.01% | (15.16%) | (77.07%) | 43.14% | 63.42% |
Revenue per Share |
93.48 | 95.64 | 95.75 | 94.80 | 97.57 | 102.08 | 116.14 | 125.57 | 137.36 | 166.51 |
Operating CF per Share |
4.07 | 3.63 | 1.61 | 2.33 | (1.03) | 18.86 | 3.38 | 2.43 | 6.92 | 10.27 |
Capex per Share |
(2.45) | (2.69) | (3.37) | (2.93) | (3.62) | (3.78) | (3.82) | (4.60) | (4.98) | (6.58) |
Free Cash Flow per Share |
1.62 | 0.95 | (1.76) | (0.60) | (4.65) | 15.08 | (0.44) | (2.17) | 1.93 | 3.68 |
Cash per Share |
1.95 | 0.28 | 0.29 | 0.92 | 4.00 | 14.51 | 1.90 | 1.74 | 5.04 | 2.15 |
Shareholders Equity per Share |
(8.68) | (12.69) | (8.79) | (9.90) | (10.18) | (13.32) | (18.82) | (12.98) | (6.19) | 15.61 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(8.68) | (12.69) | (8.79) | (9.90) | (10.18) | (13.32) | (18.82) | (12.98) | (6.19) | 15.61 |
Free Cash Flow |
216.00 | 125.00 | (229.00) | (77.00) | (590.00) | 1,742.00 | (50.00) | (245.00) | 216.00 | 408.00 |
Working Capital |
1,026.00 | 956.00 | 1,066.00 | 896.00 | 1,115.00 | 1,695.00 | 1,145.00 | 1,157.00 | 1,712.00 | 1,779.00 |
Capital Expenditures |
(327.00) | (355.00) | (439.00) | (377.00) | (459.00) | (436.00) | (435.00) | (519.00) | (557.00) | (729.00) |
Net Current Asset Value |
(11,129.00) | (12,429.00) | (12,394.00) | (12,862.00) | (13,028.00) | (13,034.00) | (14,323.00) | (13,773.00) | (14,074.00) | (15,550.00) |
EV/EBIT |
7.09 | 21.79 | 12.39 | 14.72 | 9.50 | 10.12 | 20.80 | 65.95 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
Price to Operating Income |
0.28 | 0.73 | 0.43 | 0.69 | 1.20 | 0.76 | 0.51 | 1.53 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.09 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.11 | 0.11 | 0.12 | 0.14 |
Cash ROIC |
2.27% | 1.27% | (2.21%) | (0.73%) | (5.20%) | 14.10% | (0.44%) | (1.99%) | 1.57% | 2.37% |
Accounts Receivable Turnover |
5.72 | 5.59 | 5.85 | 5.95 | 6.20 | 5.63 | 5.73 | 5.98 | 5.52 | 5.43 |
Accounts Payable Turnover |
2.12 | 2.13 | 2.37 | 2.46 | 2.53 | 2.46 | 2.53 | 2.54 | 2.72 | 2.67 |
Inventory Turnover |
5.71 | 5.91 | 5.85 | 5.58 | 5.92 | 5.70 | 5.69 | 5.57 | 5.78 | 5.68 |
Average Days of Payables |
164.88 | 171.25 | 167.02 | 142.86 | 148.36 | 145.59 | 137.62 | 137.48 | 132.09 | 120.62 |
Days of Inventory on Hand |
63.05 | 62.08 | 60.07 | 65.24 | 63.45 | 62.29 | 60.07 | 62.31 | 60.65 | 58.19 |
Average Receivables |
2,181.50 | 2,258.50 | 2,135.50 | 2,051.00 | 1,994.50 | 2,092.50 | 2,305.00 | 2,368.00 | 2,780.00 | 3,393.50 |
Average Payables |
877.50 | 912.50 | 842.50 | 801.50 | 806.50 | 797.00 | 849.00 | 927.00 | 981.00 | 1,126.50 |
Average Inventory |
326.50 | 329.50 | 340.50 | 354.00 | 345.00 | 344.50 | 378.00 | 423.00 | 462.00 | 530.00 |
Average Assets |
13,629.00 | 14,254.50 | 14,562.00 | 14,943.00 | 15,611.50 | 15,807.50 | 15,734.00 | 16,654.50 | 19,697.00 | 24,269.50 |
Average Common Equity |
(1,417.50) | (1,411.50) | (1,211.00) | (1,282.50) | (1,414.00) | (1,839.50) | (1,802.00) | (1,077.50) | 518.00 | 2,916.50 |
Columns are period end dates · fundamentals updated 6 Nov 2026